Latest news
Promising results from first UK trial of psilocybin for depression - King's College LondonKing's College London · Thu, 06 Aug 2026 13:15:24 GMTImmediate treatment needed for kind of aortic tear that killed senator - Vero NewsVero News · Thu, 06 Aug 2026 07:00:00 GMTSciSparc: Subsidiary NeuroThera Labs Launches Phase IIb - GlobeNewswireGlobeNewswire · Wed, 05 Aug 2026 12:22:00 GMTTourette drug candidate enters Phase IIb with prior 21% tic reduction - Stock TitanStock Titan · Wed, 05 Aug 2026 12:22:00 GMTFirst-of-kind Guillain-Barré drug switches off part of immune system - New ScientistNew Scientist · Thu, 30 Jul 2026 07:00:00 GMT[AIDS 2026] [Press release] ViiV Healthcare’s 2-drug regimen Dovato is as effective as 3-drug regimen Biktarvy in first-of-its-kind head-to-head study in treatment-naïve adults living with HIV - eatg.orgeatg.org · Tue, 28 Jul 2026 00:42:10 GMT